Skip to main content
. 2023 Sep 27;39(3):237–248. doi: 10.47717/turkjsurg.2023.6087

Table 3. Sociodemographic and clinical characteristics of the pa- tients participating in the study .

Quantitative variables X ± SD
Age 54.86 ± 12.17
  Median (min-max)
  54.00 (24.00-84.00)
Qualitative variables n (%)
Work at work  
No 99 (90.8)
Yes 10 (9.2)
Marital status  
Single 15 (14.3)
Married 90 (85.7)
Education status  
No 26 (23.9)
Yes 83 (76.1)
Cancer in the family  
No 83 (76.1)
Yes 26 (23.9)
Menopause  
Pre 41 (37.6)
Post 68 (62.4)
Additional disease  
No 72 (66.1)
Yes 37 (33.9)
Breast location  
Left 67 (61.5)
Right 42 (38.5)
Pathology type  
Invasive ductal carcinoma 95 (872.)
Others (mucinous, etc) 14 (12.8)
Tumor Stage (AJCC 2009 stage)  
1 11 (10.1)
2 38 (34.9)
3 52 (47.7)
4 8 (7.3)
Lymph node (AJCC 2009 stage)  
0 11 (10.1)
1 6 (5.5)
2 42 (38.5)
3 50 (45.9)
Stages  
1 1 (0.9)
2 13 (12.0)
3 94 (87.1)
Estrogen status  
Negative 16 (14.7)
Positive 93 (85.3)
Progesterone status  
Negative 27 (24.8)
Positive 82 (75.2)
HER status  
Negative 96 (88.1)
Positive 13 (11.9)
Surgical condition  
Modified radical mastectomy 37 (33.9)
Breast conserving surgery 72 (66.1)
Chemotherapy  
No 3 (2.8)
Yes 106 (97.2)
Hormone therapy  
No 16 (14.7)
Yes 93 (85.3)
x: Arithmetic mean, SD: Standard deviation.